Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.13.5317

Association Between Three eNOS Polymorphisms and Cancer Risk: a Meta-analysis  

Wu, Xun (Department of Anatomy, School of Basic Medicine Science, Southern Medical University)
Wang, Zhi-Feng (Department of Anatomy, School of Basic Medicine Science, Southern Medical University)
Xu, Yin (Department of Urology, The First Affiliated Hospital of JINAN University)
Ren, Rui (Department of Andrology, Zhongshan City People's Hospital)
Heng, Bao-Li (Department of Urology, The First Affiliated Hospital of JINAN University)
Su, Ze-Xuan (Department of Anatomy, School of Basic Medicine Science, Southern Medical University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.13, 2014 , pp. 5317-5324 More about this Journal
Abstract
Polymorphisms in the endothelial nitric oxide synthase (eNOS) gene may influence the risk of cancer, but the results are still debatable. Therefore, we performed a systematic review to provide a more complete picture and conducted a meta-analysis to derive a precise estimation. We searched PubMed, EMBASE, EBSCO, Google Scholar and China National Knowledge Infrastructure (CNKI) databases until April 2014 to identify eligible studies. Thirty-one studies with cancer patients and controls were included in the meta-analysis. Overall, the polled analysis revealed that the T-786C polymorphism was significantly associated with increased cancer risk under multiple genetic models (C vs T: OR=1.135, 95%CI=1.048-1.228; CC vs TT: OR=1.278, 95%CI=1.045-1.562; TC vsTT: OR=1.136, 95%CI=1.023-1.261; CC+TC vs TT: OR=1.159, 95%CI=1.047-1.281; CC vs TC+TT: OR=1.204, 95%CI= 1.003-1.447). G894T was associated with significant risk for females (TT vs GG: OR=1.414, 95%CI=1.056-1.892; TT vs GT+GG: OR=1.356, 95%CI=1.108-1.661) and for breast cancer (T vs G: OR=1.097, 95%CI=1.001-1.203; TT vs GG: OR=1.346, 95%CI=1.012-1.789; TT vs GT+GG: OR=1.269, 95%CI=1.028-1.566). Increased susceptibility was revealed for prostate cancer with 4a/b (ba vs bb: OR=1.338, 95%CI=1.013-1.768; aa+ba vs bb: OR=1.474, 95%CI=1.002-2.170). This meta-analysis indicated that the eNOS T-786C polymorphism is associated with elevated cancer risk; the G894T polymorphism contributes to susceptibility to breast cancer and cancer generally in females; and the 4a/b polymorphism may be associated with prostate cancer risk.
Keywords
Endothelial nitric oxide synthase; polymorphism; cancer; systematic review; meta-analysis;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Wang XL, Mahaney MC, Sim AS, et al (1997). Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol, 17, 3147-53.   DOI   ScienceOn
2 Yao L, Fang F, Zhong Y,Yu L (2010). The association between two polymorphisms of eNOS and breast cancer risk: a meta-analysis. Breast Cancer Res Treat, 124, 223-7.   DOI
3 Yeh CC, Santella RM, Hsieh LL, Sung FC,Tang RP (2009). An intron 4 VNTR polymorphism of the endothelial nitric oxide synthase gene is associated with early-onset colorectal cancer. Int J Cancer, 124, 1565-71.   DOI   ScienceOn
4 Ying L,Hofseth LJ (2007). An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer. Cancer Res, 67, 1407-10.   DOI   ScienceOn
5 Yu JX, Cui L, Zhang QY, et al (2006). Expression of NOS and HIF-1alpha in human colorectal carcinoma and implication in tumor angiogenesis. World J Gastroenterol, 12, 4660-4.   DOI
6 Yuan F, Zhang LS, Li HY, et al (2013). Influence of angiotensin I-converting enzyme gene polymorphism on hepatocellular carcinoma risk in China. DNA Cell Biol, 32, 268-73.   DOI   ScienceOn
7 Ziaei SA, Samzadeh M, Jamaldini SH, et al (2013). Endothelial nitric oxide synthase Glu298Asp polymorphism as a risk factor for prostate cancer. Int J Biol Markers, 28, 43-8.   DOI   ScienceOn
8 Zintzaras E, Grammatikou M, Kitsios GD, et al (2010). Polymorphisms of the endothelial nitric oxide synthase gene in breast cancer: a genetic association study and meta-analysis. J Hum Genet, 55, 743-8.   DOI   ScienceOn
9 Ryk C, Wiklund NP, Nyberg T,de Verdier PJ (2011). Polymorphisms in nitric-oxide synthase 3 may influence the risk of urinary-bladder cancer. Nitric Oxide, 25, 338-43.   DOI   ScienceOn
10 Reiche EM, Nunes SO,Morimoto HK (2004). Stress, depression, the immune system, and cancer. Lancet Oncol, 5, 617-25.   DOI   ScienceOn
11 Riener EK, Hefler LA, Grimm C, et al (2004). Polymorphisms of the endothelial nitric oxide synthase gene in women with vulvar cancer. Gynecol Oncol, 93, 686-90.   DOI   ScienceOn
12 Unal MT, Karabulut HG, Gumus-Akay G, et al (2010). Endothelial nitric oxide synthase gene polymorphism in gastric cancer. Turk J Gastroenterol, 21, 338-44.   DOI
13 Safarinejad MR, Safarinejad S, Shafiei N,Safarinejad S (2013). Effects of the T-786C, G894T, and Intron 4 VNTR (4a/b) polymorphisms of the endothelial nitric oxide synthase gene on the risk of prostate cancer. Urol Oncol, 31, 1132-40.   DOI   ScienceOn
14 Sanli O, Kucukgergin C, Gokpinar M, et al (2011). Despite the lack of association between different genotypes and the presence of prostate cancer, endothelial nitric oxide synthase a/b (eNOS4a/b) polymorphism may be associated with advanced clinical stage and bone metastasis. Urol Oncol, 29, 183-8.   DOI   ScienceOn
15 Tu YT, Tao J, Liu YQ, et al (2006). Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in human malignant melanoma and their relation to angiogenesis. Clin Exp Dermatol, 31, 413-8.   DOI   ScienceOn
16 Verim L, Toptas B, Ozkan NE, et al (2013). Possible relation between the NOS3 Gene GLU298ASP polymorphism and bladder cancer in Turkey. Asian Pac J Cancer Prev, 14, 665-8.   과학기술학회마을   DOI   ScienceOn
17 Marangoni K, Neves AF, Cardoso AM, et al (2006). The endothelial nitric oxide synthase Glu-298-Asp polymorphism and its mRNA expression in the peripheral blood of patients with prostate cancer and benign prostatic hyperplasia. Cancer Detect Prev, 30, 7-13.   DOI   ScienceOn
18 Li Y, Ambrosone CB, McCullough MJ, et al (2009). Oxidative stress-related genotypes, fruit and vegetable consumption and breast cancer risk. Carcinogenesis, 30, 777-84.   DOI   ScienceOn
19 Marangoni K, Araujo TG, Neves AF,Goulart LR (2008). The -786T>C promoter polymorphism of the NOS3 gene is associated with prostate cancer progression. BMC Cancer, 8, 273.   DOI   ScienceOn
20 Lu J, Wei Q, Bondy ML, et al (2006). Promoter polymorphism (-786t>C) in the endothelial nitric oxide synthase gene is associated with risk of sporadic breast cancer in non-Hispanic white women age younger than 55 years. Cancer, 107, 2245-53.   DOI   ScienceOn
21 Marsden PA, Heng HH, Scherer SW, et al (1993). Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem, 268, 17478-88.
22 Medeiros R, Morais A, Vasconcelos A, et al (2002). Endothelial nitric oxide synthase gene polymorphisms and genetic susceptibility to prostate cancer. Eur J Cancer Prev, 11, 343-50.   DOI   ScienceOn
23 Nakayama M, Yasue H, Yoshimura M, et al (1999). T-786 -> C mutation in the 5 '-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation, 99, 2864-70.   DOI   ScienceOn
24 Ozturk E, Dikensoy E, Balat O, et al (2011). Association of endothelial nitric oxide synthase gene polymorphisms with endometrial carcinoma: a preliminary study. J Turk Ger Gynecol Assoc, 12, 229-33.
25 Perera FP (1997). Environment and cancer: who are susceptible? Science, 278, 1068-73.   DOI   ScienceOn
26 Ghilardi G, Biondi ML, Cecchini F, et al (2003). Vascular invasion in human breast cancer is correlated to T786C polymorphism of NOS3 gene. Nitric Oxide, 9, 118-22.   DOI   ScienceOn
27 Jang MJ, Jeon YJ, Kim JW, et al (2013). Association of eNOS polymorphisms (-786T>C, 4a4b, 894G>T) with colorectal cancer susceptibility in the Korean population. Gene, 512, 275-81.   DOI   ScienceOn
28 Hao YJ, Montiel R,Huang YS (2010). Endothelial nitric oxide synthase (eNOS) 894 G > T polymorphism is associated with breast cancer risk: a meta-analysis. Breast Cancer Res Treat, 124, 809-13.   DOI
29 Harman E, Karadeniz M, Biray C, et al (2009). The relation of adiponectin and tumor necrosis factor alpha levels between endothelial nitric oxide synthase, angiotensin-converting enzyme, transforming growth factor beta, and tumor necrosis factor alpha gene polymorphism in adrenal incidentalomas. J Endocrinol Invest, 32, 881-8.   DOI
30 Hefler LA, Ludwig E, Lampe D, et al (2002). Polymorphisms of the endothelial nitric oxide synthase gene in ovarian cancer. Gynecol Oncol, 86, 134-7.   DOI   ScienceOn
31 Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.   DOI
32 Lee KM, Choi JY, Lee JE, et al (2007). Genetic polymorphisms of NOS3 are associated with the risk of invasive breast cancer with lymph node involvement. Breast Cancer Res Treat, 106, 433-8.   DOI
33 Lee KM, Kang D, Park SK, et al (2009). Nitric oxide synthase gene polymorphisms and prostate cancer risk. Carcinogenesis, 30, 621-5.   DOI   ScienceOn
34 Conde MC, Ramirez-Lorca R, Lopez-Jamar JM, et al (2006). Genetic analysis of caveolin-1 and eNOS genes in colorectal cancer. Oncol Rep, 16, 353-9.
35 Chen SQ, Hong BB, Lin XD, et al (2010). Association of the eNOS G894T polymorphism with the development and progression of gastric cancer. J Chongqing Med Univ, 35, 1816-9.
36 Erdamar S, Bagci P, Oz B, Dirican A (2006). Correlation of endothelial nitric oxide synthase and vascular endothelial growth factor expression with malignancy in patients with astrocytic tumors. J BUON, 11, 213-6.
37 Chen Z, Yuhanna IS, Galcheva-Gargova Z, et al (1999). Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest, 103, 401-6.   DOI   ScienceOn
38 Chen ZG, Zhou W, Chen W, Tao ZH,Gu YF (2009). Association of G894T polymorphism in endothelial nitric oxide synthase gene with prostate cancer. Chin J Healthy Lab Technol, 19, 289-91.
39 Dong LM, Potter JD, White E, et al (2008). Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA, 299, 2423-36.   DOI   ScienceOn
40 Fu H, Zhang Y, Jin L, Ding Z (2011). Endothelial nitric oxide synthase (eNOS) G894T polymorphism is not associated with breast cancer risk: new evidence. Breast Cancer Res Treat, 128, 595-8.   DOI
41 Fukumura D, Gohongi T, Kadambi A, et al (2001). Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci U S A, 98, 2604-9.   DOI   ScienceOn
42 Funke S, Hoffmeister M, Brenner H,Chang-Claude J (2009). Effect modification by smoking on the association between genetic polymorphisms in oxidative stress genes and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev, 18, 2336-8.   DOI   ScienceOn
43 Are C, Rajaram S, Are M, et al (2013). A review of global cancer burden: trends, challenges, strategies, and a role for surgeons. J Surg Oncol, 107, 221-6.   DOI   ScienceOn
44 Burke AJ, Sullivan FJ, Giles FJ,Glynn SA (2013). The yin and yang of nitric oxide in cancer progression. Carcinogenesis, 34, 503-12.   DOI   ScienceOn
45 Arikan S, Cacina C, Guler E, et al (2012). The effects of NOS3 Glu298Asp variant on colorectal cancer risk and progression in Turkish population. Mol Biol Rep, 39, 3245-9.   DOI   ScienceOn
46 Barbieri A, Palma G, Rosati A, et al (2012). Role of endothelial nitric oxide synthase (eNOS) in chronic stress-promoted tumour growth. J Cell Mol Med, 16, 920-6.   DOI   ScienceOn
47 Brankovic A, Brajuskovic G, Nikolic Z, et al (2013). Endothelial nitric oxide synthase gene polymorphisms and prostate cancer risk in Serbian population. Int J Exp Pathol, 94, 355-61.   DOI   ScienceOn
48 Amasyali AS, Kucukgergin C, Erdem S, et al (2012). Nitric oxide synthase (eNOS4a/b) gene polymorphism is associated with tumor recurrence and progression in superficial bladder cancer cases. J Urol, 188, 2398-403.   DOI   ScienceOn
49 Royo JL, Moreno-Nogueira JA, Galan JJ, et al (2006). Lack of association between NOS3 Glu298Asp and breast cancer risk: a case-control study. Breast Cancer Res Treat, 100, 331-3.   DOI
50 Hefler LA, Grimm C, Lantzsch T, et al (2006). Polymorphisms of the endothelial nitric oxide synthase gene in breast cancer. Breast Cancer Res Treat, 98, 151-5.   DOI